Second Genome, Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Second Genome, Inc..The latest application filed is for "proteins for the treatment of epithelial barrier function disorders".

Company Profile

13.14.23

Second Genome, Inc. - Brisbane CA US
Second Genome, Inc. - San Francisco CA US
Second Genome, Inc. - South San Francisco CA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Proteins For The Treatment Of Epithelial Barrier Function Disorders App 20220257703 - Han; Andrew Wonhee ; et al.	2022-08-18
Streptococcus australis as a biotherapeutic Grant 11,389,487 - Han , et al. July 19, 2	2022-07-19
Proteins For The Treatment Of Epithelial Barrier Function Disorders App 20220185849 - Han; Andrew Wonhee ; et al.	2022-06-16
Gemella sanguinis as a biotherapeutic Grant 11,344,584 - Han , et al. May 31, 2	2022-05-31
Proteins For The Treatment Of Epithelial Barrier Function Disorders App 20220106365 - Han; Andrew Wonhee ; et al.	2022-04-07
Microbially Derived Peptides And Proteins For Immunotherapy App 20220089653 - Katlinskaya; Yuliya ; et al.	2022-03-24
Proteins for the treatment of epithelial barrier function disorders Grant 11,273,198 - Han , et al. March 15, 2	2022-03-15
Proteins for the treatment of epithelial barrier function disorders Grant 11,207,376 - Han , et al. December 28, 2	2021-12-28
Lactococcus Lactis Expression System For Delivering Proteins Efficacious For The Treatment Of Epithelial Barrier Function Disorders App 20210380994 - Willcoxon; Michi Izumi ; et al.	2021-12-09
Proteins for the treatment of epithelial barrier function disorders Grant 11,174,293 - Han , et al. November 16, 2	2021-11-16
Anaerostipes Hadrus For Use In Promoting Health App 20210268037 - Kawana; Shoko ; et al.	2021-09-02
Proteins for the Treatment of Epithelial Barrier Function Disorders App 20210230236 - Butterfield; Cristina N. ; et al.	2021-07-29
Roseburia Hominis, Eubacterium Eligens, And Combinations Thereof As Biotherapeutics App 20200376044 - Han; Andrew Wonhee ; et al.	2020-12-03
Streptococcus Australis As A Biotherapeutics App 20200237829 - Han; Andrew Wonhee ; et al.	2020-07-30
Gemella Sanguinis As A Biotherapeutics App 20200237830 - Han; Andrew Wonhee ; et al.	2020-07-30
Proteins For The Treatment Of Epithelial Barrier Function Disorders App 20200181206 - Han; Andrew Wonhee ; et al.	2020-06-11
Proteins For The Treatment Of Epithelial Barrier Function Disorders App 20200171125 - HAN; Andrew Wonhee ; et al.	2020-06-04
Proteins For The Treatment Of Epithelial Barrier Function Disorders App 20200148728 - Han; Andrew Wonhee ; et al.	2020-05-14
Methods For Validation Of Microbiome Sequence Processing And Differential Abundance Analyses Via Multiple Bespoke Spike-in Mixtu App 20200140925 - Chow; Cheryl-Emiliane T. ; et al.	2020-05-07
Proteins For The Treatment Of Epithelial Barrier Function Disorders App 20200061152 - Han; Andrew Wonhee ; et al.	2020-02-27
Leveraging Sequence-based Fecal Microbial Community Survey Data To Identify A Composite Biomarker For Colorectal Cancer App 20200011873 - Desantis; Todd Zachary ; et al.	2020-01-09
Microbial Ecology Shift Assay App 20190136287 - Steger; Rachel ; et al.	2019-05-09
Proteins for the treatment of epithelial barrier function disorders Grant 10,251,933 - Han , et al.	2019-04-09
Microbial ecology shift assay Grant 10,150,982 - Steger , et al. Dec	2018-12-11
Proteins For The Treatment Of Epithelial Barrier Function Disorders App 20180289770 - HAN; Andrew Wonhee ; et al.	2018-10-11
Microbial Ecology Shift Assay App 20160145670 - Steger; Rachel ; et al.	2016-05-26
Microbiome Modulation Index App 20150337349 - Kuczynski; Justin ; et al.	2015-11-26

Company Registrations

NCAGE Code	5WG03	SECOND GENOME, INC.
CAGE Code	5WG03	SECOND GENOME, INC.
S.A.M. Registration	5WG03 [961590895]	SECOND GENOME, INC.
SEC	0001527224	Second Genome, Inc. of DELAWARE

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.